OMass Therapeutics raises $295M Series C
OMass Therapeutics: OMass Therapeutics is a biotech company developing small molecule therapeutics.
- Round
- Series C
- Amount
- $295M (€275M)
- Announced
- Lead investors
- Bain Capital Life Sciences, Forbion, Novo Holdings
- Also investing
- Janus Henderson Investors, SV Health Investors, Jefferson Life Sciences
- Headquarters
- Oxford, United Kingdom
Source (found by the agent, not yet verified)
More: OMass Therapeutics funding history · rounds in October 2026 · rounds in United Kingdom